1.A Stent Graft Infection after Abdominal Aortic Aneurysm Repair
Masakazu Aoki ; Kenichi Kamiya ; Shinji Ogawa ; Hiroshi Baba ; Yasuhide Okawa
Japanese Journal of Cardiovascular Surgery 2011;40(3):125-129
We present a rare case of stent graft infection. A 69-year-old man, who had undergone endovascular repair of an abdominal aortic aneurysm with an Inoue stent graft 5 years previously, was admitted with high-grade fever. An abscess around an abdominal aortic aneurysm was found on abdominal computed tomography (CT) and he was given a diagnosis of stent graft infection. The stent graft was removed and vascular reconstruction was performed using a Gelweave graft bonded with rifampicin. The graft was then covered with the greater omentum, and he was discharged on the 27th postoperative day.
2.Recent Trends of the Treatment for Carcinomas of the Biliary Tract and Pancreas. A Report from an Institution in Gifu Pref.
Tetsuya TAJIKA ; Nobuki KAMEOKA ; Jun MORIOKA ; Hiroshi OKAWA ; Masahiko KATO ; Toshikazu ONUMA
Journal of the Japanese Association of Rural Medicine 1994;42(5):1049-1055
During the 13-year period from 1979 Jan. to 1992 Apr., 93 patients with carcinomas of the biliary tract including the ampulla of Vater and the pancreas were surgically treated at Kumiai General Hospital in the northern Hida district of Gifu Prefecture. In these 93 patients, 31 were diagnosed as suffering from carcinomas of the extrahepatic bile duct; 19, gallbladder carcinomas; 5, carcinomas of the ampulla of Vater and 38, pancreatic carcinomas. But the majority of these patients were classified into the far-advanced stages in accordance with the Japanese stage classification. Resectability was 58.1% in carcinoma of the extrahepatic bile duct, 42.1% in gallbladder carcinoma, 100% in periampullary carcinoma and 31.5% in pancreatic carcinoma and their survival rates were discouragingly low. To improve the postoperative results, it should be advocated that early diagnosis and treatment are most important for biliary tract carcinoma of m and fm in pathological depth, gallbladder carcinoma of m and pm in depth and small pancreatic carcinoma smaller than 2 cm.
3.Left Ventricular Shape and Regional Wall Motion in Relation to the Prognosis of Ischemic Mitral Regurgitation.
Hiroshi Baba ; Yasuhide Okawa ; Masahiro Toyama ; Tsuneo Tanaka ; Masaki Hashimoto ; Koji Matsumoto
Japanese Journal of Cardiovascular Surgery 1999;28(5):293-298
Ischemic mitral regurgitation (IMR) is a serious and increasingly common clinical disorder, but at present, the relationship between left ventricular shape and IMR is not completely understood. Thirty patients with moderate or severe IMR who underwent mitral valve surgery combined with coronary artery bypass grafting were studied retrospectively. Left ventricular shape, left ventricular regional wall motion, hemodynamic index, condition of the coronary artery, severity of IMR and long term results were assessed using ventriculography and angiography. Left ventricular shape at end diastole and end systole were quantified based upon the ratio of the major-to-minor axis and the sphericity index. Hospital mortality rate was 13.3%, 5 years survival rates were 10.5%, and 5-year rate of freedom from congestive heart failure (CHF) were 7.8%. Significant difference between cardiac deaths (n=11) and survivors (n=19) included requiring intensive care admission, requiring intra-aortic balloon pumping, recurrent myocardial infarction, the ratio of the major-minor axis at end diastole, the sphericity index at diastole, and the sphericity index at end systole. Multivariable regression analyses were performed with the Cox proportional hazards model. Significant determinants of survival were the sphericity index at end systole and LV regional wall motion at the site of the anterobasal segment or apex. These findings indicate that the shape of the LV and LV regional wall motion in IMR may be important determinants of prognosis and suggest that surgical attention to shape may be helpful for mitral valve surgery.
4.Intermittent compressive force induces cell cycling and reduces apoptosis in embryoid bodies of mouse induced pluripotent stem cells.
Jeeranan MANOKAWINCHOKE ; Phoonsuk LIMRAKSASIN ; Hiroko OKAWA ; Prasit PAVASANT ; Hiroshi EGUSA ; Thanaphum OSATHANON
International Journal of Oral Science 2022;14(1):1-1
In vitro manipulation of induced pluripotent stem cells (iPSCs) by environmental factors is of great interest for three-dimensional (3D) tissue/organ induction. The effects of mechanical force depend on many factors, including force and cell type. However, information on such effects in iPSCs is lacking. The aim of this study was to identify a molecular mechanism in iPSCs responding to intermittent compressive force (ICF) by analyzing the global gene expression profile. Embryoid bodies of mouse iPSCs, attached on a tissue culture plate in 3D form, were subjected to ICF in serum-free culture medium for 24 h. Gene ontology analyses for RNA sequencing data demonstrated that genes differentially regulated by ICF were mainly associated with metabolic processes, membrane and protein binding. Topology-based analysis demonstrated that ICF induced genes in cell cycle categories and downregulated genes associated with metabolic processes. The Kyoto Encyclopedia of Genes and Genomes database revealed differentially regulated genes related to the p53 signaling pathway and cell cycle. qPCR analysis demonstrated significant upregulation of Ccnd1, Cdk6 and Ccng1. Flow cytometry showed that ICF induced cell cycle and proliferation, while reducing the number of apoptotic cells. ICF also upregulated transforming growth factor β1 (Tgfb1) at both mRNA and protein levels, and pretreatment with a TGF-β inhibitor (SB431542) prior to ICF abolished ICF-induced Ccnd1 and Cdk6 expression. Taken together, these findings show that TGF-β signaling in iPSCs enhances proliferation and decreases apoptosis in response to ICF, that could give rise to an efficient protocol to manipulate iPSCs for organoid fabrication.
Animals
;
Apoptosis
;
Cell Cycle
;
Cell Differentiation
;
Embryoid Bodies
;
Induced Pluripotent Stem Cells/metabolism*
;
Mice
;
Transforming Growth Factor beta/pharmacology*